Microban International, a global leader in built-in antimicrobial product protection, announced today a new initiative designed to help medical device manufacturers get to market quicker with antimicrobial solutions for 510(k) registered medical devices used in hospitals and other healthcare facilities.
Helthcare-acquired infections (HAIs) are responsible for approximately 100,000 deaths per year and incur in excess of $20 billion in healthcare costs. "Our expertise utilizing a breadth of antimicrobial technologies enables us to help manufacturers of medical devices develop safer and more effective antimicrobial solutions for their products and provides an important resource to help address the growing concern over hospital acquired infections," said David Meyers, president and CEO of Microban International.
Microban has an extensive portfolio of organic, inorganic and organometallic antimicrobial technologies which enable it to choose the optimal technology for the device. It works closely with customers to engineer antimicrobial solutions that are designed to meet the specific needs of each unique device application, evaluating important criteria such as: antimicrobial performance utilizing industry standard protocols and testing for specific microorganisms and relevant kill times; durability requirements and exposure time periods; product usage environment; manufacturing parameters; and necessary regulatory approvals.
With more than 20 years of experience engineering antimicrobial solutions across a breadth of product applications and materials including expertise with thermoplastics, cross-linked thermosets, coatings and textiles Microban says it can help medical device manufacturers to more effectively and accurately screen and optimize potential antimicrobial technologies. In addition, its onsite state-of-the-art microbiology laboratory utilizes a high throughput quantitative testing system that enables Microban to quickly and reliably deliver accurate data and proof of concept studies.
Microban offers full service support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance. For more information, medical manufacturers should visit http://www.microban.com/microban-medical.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care
May 5th 2025Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.